Vitamin D 用于 高血压
C 证据 来自小型研究的证据有限，但存在一些积极信号。Meta-analyses show modest BP reduction (-2-6 mmHg) in deficient populations only. VITAL trial was negative for cardiovascular endpoints. Research suggests benefits may be limited to correcting deficiency.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'heartcited.com';
const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dhigh\u002Dblood\u002Dpressure';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
结论
Meta-analyses show modest BP reduction (-2-6 mmHg) in deficient populations only. VITAL trial was negative for cardiovascular endpoints. Research suggests benefits may be limited to correcting deficiency.
Key Study Findings
Observational Study
n=2582
Relationship Between Serum Vitamins and Cognitive Impairment in the Elderly: A Study Based on the …
Dose: None
vs: None
Outcome: Cognitive impairment risk
效果: OR=0.695 (Vit D); OR=0.777 (FA)
p=0.003 (Vit D); p=0.034 (FA)
研究人群: Elderly participants aged 60+ from NHANES 2011-2014
Observational Study
n=72
Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
Dose: None
vs: Healthy controls
Outcome: CVR and systemic inflammation in alopecia areata
效果: None
None
研究人群: 36 AA patients vs 36 matched controls, mean age 39
review
Top studies of 2024 relevant to primary care: From the PEER team.
Dose: None
vs: Placebo
效果: None
None
Review
Dietary supplements and prevention of preeclampsia.
Dose: 500 mg daily
vs: Placebo
Outcome: Preeclampsia risk reduction
效果: ~50% risk reduction
None
研究人群: Pregnant women with low calcium intake
Observational Study
n=2065
Cytomegalovirus (CMV), oxidative stress, and inflammation: implications for immunosenescence and age-related diseases in the MARK-AGE …
Dose: None
vs: None
Outcome: CMV IgG association with oxidative stress markers
效果: None
None
研究人群: Age-stratified general population (MARK-AGE RASIG cohort)
Systematic Review
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.
Dose: Disease-modifying agents (tolvaptan, etc.)
vs: Placebo or standard care
Outcome: Kidney disease progression
效果: None
None
研究人群: Patients with ADPKD
Key Statistics
20
研究数量
30000
受试者
↔
Mixed
C
等级
Referenced Papers
Brain and behavior
2026
Hypertension research : …
2025
10 次引用
Biogerontology
2025
Canadian family physician …
2025
Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
Observational
Acta dermatovenerologica Croatica …
2025
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.
Systematic Review
The Cochrane database …
2024
1 次引用
Health science reports
2023
3 次引用
Nutrients
2022
14 次引用
Current journal of …
2022
11 次引用
Sleep patterns modify the association of 25(OH)D with poor cardiovascular health in pregnant women.
Other
Frontiers in nutrition
2022
4 次引用
Family practice
2022
2 次引用
Nutrients
2021
113 次引用
Journal of the …
2021
23 次引用
Nutrients
2020
219 次引用
Medical hypotheses
2016
105 次引用
Annals of the …
2016
89 次引用
International journal of …
2016
28 次引用
British journal of …
2013
156 次引用
The Annals of …
2013
Contemporary clinical trials
2012
522 次引用
Acta medica Indonesiana
2007
4 次引用
Journal of the …
2007
American journal of …
2006
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 600-800 IU/day
- deficiencycorrection:
- 4,000-5,000 IU/day (under medical supervision)
- cardiovascularsupport:
- 1,000-2,000 IU/day
上限： 4,000 IU/day (100 mcg)
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Positive | 2582 |
| None | -- | Negative | 72 |
| None | -- | Mixed | -- |
| 500 mg daily | -- | Positive | -- |
| None | -- | Negative | 2065 |
| Disease-modifying agents (tolvaptan, etc.) | -- | Positive | -- |
| 36% | -- | Mixed | -- |
| not applicable | -- | Neutral | 103 |
最佳服用时间： With a meal containing fat for better absorption
Safety & Side Effects
已报告的副作用
- ⚠ Hypercalcemia at very high doses (fatigue, nausea, kidney stones)
- ⚠ Constipation
- ⚠ Generally very safe at recommended doses
已知相互作用
- ● Thiazide diuretics (may increase hypercalcemia risk)
- ● Statins (theoretical interaction via CYP enzymes)
- ● Corticosteroids (may reduce vitamin D absorption)
- ● Weight loss medications (may reduce absorption of fat-soluble vitamins)
可耐受最高摄入量： 4,000 IU/day (100 mcg)
在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Vitamin D help with 高血压?
Based on 20 studies with 30,000 participants, there is limited but promising evidence that Vitamin D may support 高血压 management. Our evidence grade is C (Some Evidence).
How much Vitamin D should I take for 高血压?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (fatigue, nausea, kidney stones), Constipation, Generally very safe at recommended doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and 高血压?
We rate the evidence as Grade C (Some Evidence). This rating is based on 20 peer-reviewed studies with 30,000 total participants. The overall direction of effect is mixed.
Related Evidence
Vitamin D 用于其他健康状况
References
- [1] Jiarui Miao et al.. Brain Behav. 2026. Relationship Between Serum Vitamins and Cognitive Impairment in the Elderly: A Study Based on the NHANES Database. doi:10.1002/brb3.71181 PubMed
- [2] Takafumi Ushida et al.. Hypertens Res. 2025. Dietary supplements and prevention of preeclampsia. doi:10.1038/s41440-025-02144-9 PubMed
- [3] Laura Cianfruglia et al.. Biogerontology. 2025. Cytomegalovirus (CMV), oxidative stress, and inflammation: implications for immunosenescence and age-related diseases in the MARK-AGE population. doi:10.1007/s10522-025-10288-x PubMed
- [4] Samantha S Moe et al.. Can Fam Physician. 2025. Top studies of 2024 relevant to primary care: From the PEER team. doi:10.46747/cfp.7105309 PubMed
- [5] Alberto Soto-Moreno et al.. Acta Dermatovenerol Croat. 2025. Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study. PubMed
- [6] Kitty St Pierre et al.. Cochrane Database Syst Rev. 2024. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. doi:10.1002/14651858.CD010294.pub3 PubMed
- [7] Elham Hamidpour et al.. Health Sci Rep. 2023. Effects of age and sex on the comorbidities of alopecia areata: A cross-sectional hospital-based study. doi:10.1002/hsr2.1444 PubMed
- [8] Ninghao Huang et al.. Nutrients. 2022. Observational and Genetic Associations of Modifiable Risk Factors with Aortic Valve Stenosis: A Prospective Cohort Study of 0.5 Million Participants. doi:10.3390/nu14112273 PubMed
- [9] Mohammad Yazdchi et al.. Curr J Neurol. 2022. Sleep status in multiple sclerosis: Role of vitamin D and body mass index. doi:10.18502/cjn.v21i2.10489 PubMed
- [10] Wan-Jun Yin et al.. Front Nutr. 2022. Sleep patterns modify the association of 25(OH)D with poor cardiovascular health in pregnant women. doi:10.3389/fnut.2022.1013960 PubMed
- [11] Izolde Bouloukaki et al.. Fam Pract. 2022. Vitamin D levels in primary care patients: correlations with clinical, seasonal, and quality-of-life parameters. doi:10.1093/fampra/cmac012 PubMed
- [12] Giulia Marrone et al.. Nutrients. 2021. Vegan Diet Health Benefits in Metabolic Syndrome. doi:10.3390/nu13030817 PubMed
- [13] Sushil K Jain et al.. J Am Coll Nutr. 2021. l-Cysteine Stimulates the Effect of Vitamin D on Inhibition of Oxidative Stress, IL-8, and MCP-1 Secretion in High Glucose Treated … doi:10.1080/07315724.2020.1850371 PubMed
- [14] Tomohiro Bito et al.. Nutrients. 2020. Potential of Chlorella as a Dietary Supplement to Promote Human Health. doi:10.3390/nu12092524 PubMed
- [15] S C Gominak. Med Hypotheses. 2016. Vitamin D deficiency changes the intestinal microbiome reducing B vitamin production in the gut. The resulting lack of pantothenic acid … doi:10.1016/j.mehy.2016.07.007 PubMed
- [16] Katherine L Tucker. Ann N Y Acad Sci. 2016. Nutrient intake, nutritional status, and cognitive function with aging. doi:10.1111/nyas.13062 PubMed
- [17] Tee Wei Siah et al.. Int J Trichology. 2016. Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. doi:10.4103/0974-7753.188033 PubMed
- [18] S Basit. Br J Biomed Sci. 2013. Vitamin D in health and disease: a literature review. doi:10.1080/09674845.2013.11669951 PubMed
- [19] Amanda M Huskey et al.. Ann Pharmacother. 2013. Occurrence of milnacipran-associated morbilliform rash and serotonin toxicity. doi:10.1345/aph.1R474 PubMed
- [20] Joann E Manson et al.. Contemp Clin Trials. 2012. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and … doi:10.1016/j.cct.2011.09.009 PubMed
- [21] Eka Ginanjar et al.. Acta Med Indones. 2007. Vitamin D and autoimmune disease. PubMed
- [22] Barbara J Messinger-Rapport et al.. J Am Med Dir Assoc. 2007. Intensive session: New approaches to medical issues in long-term care. doi:10.1016/j.jamda.2007.07.002 PubMed
- [23] Wen-Ching Chen et al.. Am J Kidney Dis. 2006. Sleep behavior disorders in a large cohort of chinese (Taiwanese) patients maintained by long-term hemodialysis. doi:10.1053/j.ajkd.2006.04.079 PubMed
- [24] P R Koninckx et al.. Maturitas. 1993. Endometrial effects during hormone replacement therapy with a sequential oestradiol valerate/cyproterone acetate preparation. doi:10.1016/0378-5122(93)90054-l PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。